Laurent Weekers

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial

Fádi Fakhouri, Maryvonne Hourmant, Josep M. Campistol et al. · American Journal of Kidney Diseases · 2016 · 308 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial

Ina Jochmans, Aukje Brat, Lucy Davies et al. · The Lancet · 2020 · 191 citations · Full text

Medicine, Nephrology, Surgery +10

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)

Guideline Development Group., Henk J.G. Bilo, Luís Coentrão et al. · Nephrology Dialysis Transplantation · 2015 · 154 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

Jan Menne, Yahsou Delmas, Fádi Fakhouri et al. · BMC Nephrology · 2019 · 127 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study

Pauline Erpicum, Laurent Weekers, Olivier Detry et al. · Kidney International · 2018 · 125 citations · Full text

Medicine, Nephrology, Translational Sciences +15